We are live on
!
Find out more
ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.77B
1-Year Est. Return
63.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.09%
AUM
$3.82B
AUM Growth
+$199M
(+5.5%)
Cap. Flow
-$73.9M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
23.54%
Holding
140
New
13
Increased
54
Reduced
65
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAPE
SAPIENT CORP
SAPE
|
+$29.6M |
| 2 |
TriMas Corp
TRS
|
+$28.7M |
| 3 |
Group 1 Automotive
GPI
|
+$18.5M |
| 4 |
SPNC
Spectranetics Corp
SPNC
|
+$16.5M |
| 5 |
EPAM Systems
EPAM
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$92.3M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$48.6M |
| 3 |
Align Technology
ALGN
|
+$29.7M |
| 4 |
A.O. Smith
AOS
|
+$21.8M |
| 5 |
ALTR
Altera Corp
ALTR
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.9% |
| 2 | Technology | 16.56% |
| 3 | Consumer Discretionary | 15.06% |
| 4 | Healthcare | 10.76% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Boeing
BA
$183B
| $280K | 0.01% |
2,050
+10
| +0.5% | +$1.3K |
|
127
JPMorgan Chase
JPM
$948B
| $252K | 0.01% |
4,309
+22
| +0.5% | +$1.21K |
|
128
Blackrock
BLK
$176B
| $251K | 0.01% |
794
+4
| +0.5% | +$1.19K |
|
129
ExxonMobil
XOM
$633B
| $217K | 0.01% |
+2,144
| New | +$198K |
|
|
BAY
130
DELISTED
BAYER AG SPONS ADR
BAY
| $217K | 0.01% |
+1,543
| New | +$217K |
|
131
Chevron
CVX
$367B
| $206K | 0.01% |
+1,652
| New | +$200K |
|
132
CVS Health
CVS
$123B
| $202K | 0.01% |
+2,829
| New | +$182K |
|
|
SGMO
133
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $143K | ﹤0.01% |
+10,275
| New | +$118K |
|
|
CORV
134
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $69K | ﹤0.01% |
+11,055
| New | +$58K |
|
|
CASM
135
DELISTED
CAS Medical Systems, Inc.
CASM
| $44K | ﹤0.01% |
+25,842
| New | +$40.3K |
|
136
Baxter International
BAX
$14.1B
| – | – |
-206,087
| Closed | -$7.35M |
|
|
CTXS
137
DELISTED
Citrix Systems Inc
CTXS
| – | – |
-160,278
| Closed | -$9.01M |
|
|
ARIA
138
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – |
-2,642,090
| Closed | -$48.6M |
|
|
ALTR
139
DELISTED
Altera Corp
ALTR
| – | – |
-322,550
| Closed | -$12M |
|
|
SLXP
140
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| – | – |
-1,380,815
| Closed | -$92.3M |
|
Similar funds
CGH
GD
HHAM
SLF
NMC
NM
BCMIO
UF
Oak Ridge Investments's Q4 2013 Portfolio in Review
As of Q4 2013, Oak Ridge Investments held 140 positions worth $3.82B, up 5.5% from $3.62B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Oak Ridge Investments's Q4 2013 filing shows 13 new, 54 increased, 65 reduced and 5 closed positions. Its largest new stake was SAPIENT CORP: 1,864,285 shares worth $32.4M. The largest sale was SALIX PHARMACEUTICALS LTD DEL, an estimated $92.3M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Oak Ridge Investments's largest Q4 2013 buy was SAPIENT CORP: 1,864,285 shares worth $32.4M.
- Oak Ridge Investments added most to Group 1 Automotive in Q4 2013, an estimated $18.5M increase.
- Oak Ridge Investments's biggest Q4 2013 reduction was Align Technology, cutting an estimated $29.7M.
- Oak Ridge Investments fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2013, selling an estimated $92.3M.
- Oak Ridge Investments's ten largest holdings make up 24% of its $3.82B portfolio in Q4 2013.
- Oak Ridge Investments opened 13 new positions and closed 5 in Q4 2013.
- Oak Ridge Investments's portfolio value rose 5.5% quarter-over-quarter to $3.82B.
Based on Oak Ridge Investments's 13F filing for Q4 2013, filed 3 Feb 2014.